Submitting to PLoS ONE.

01 About PLoS ONE

PLoS ONE is an open-access, peer-reviewed journal published by the Public Library of Science. It occupies a distinctive position in scholarly publishing: rather than restricting its scope to a single discipline, PLoS ONE publishes scientifically sound research across a wide range of fields, making it one of the most genuinely multidisciplinary venues in academic publishing. With over 339,866 works published and more than 12,362,300 citations accumulated, it is among the largest and most-cited journals in existence. Its h-index of 596 reflects the sustained influence of work published across its pages.

The journal's coverage spans biochemistry, genetics and molecular biology, medicine, molecular biology, immunology and microbiology, environmental science, infectious diseases, and ecology, evolution, behavior and systematics, among other areas. This breadth means that researchers working at disciplinary intersections (combining, say, environmental science with public health, or molecular biology with clinical medicine) will find PLoS ONE a natural home for work that resists easy categorization. The journal's open-access model ensures that published research is freely available to readers worldwide, which has contributed significantly to its reach and citation impact. For authors across the sciences and adjacent fields, this publication represents a high-visibility platform where methodological rigor, rather than perceived novelty or disciplinary prestige, is the primary editorial criterion.

02 Recent Representative Work

The following papers, all published in 2025, illustrate the range of research currently appearing in PLoS ONE. Authors preparing a submission may find it useful to read recent work in their area to calibrate scope, depth, and framing before finalizing their manuscript.

03 Common Methodology Concerns

Because PLoS ONE publishes across medicine, molecular biology, and the life sciences, reviewers bring a correspondingly wide set of methodological expectations to each submission. Understanding the concerns most commonly raised, and addressing them before submission, can meaningfully improve a manuscript's chances of moving smoothly through review.

For clinical and epidemiological work, adherence to established reporting guidelines is a baseline expectation, not an optional enhancement. Reviewers will check whether randomized controlled trials follow CONSORT, whether observational studies conform to STROBE, and whether systematic reviews and meta-analyses are structured according to PRISMA. These frameworks exist because transparent, standardized reporting allows readers to assess the validity of findings independently. Alongside reporting guidelines, reviewers in medicine-adjacent fields pay close attention to sample size justification: a power analysis should appear in the methods section, explaining the assumptions behind the target sample size and what effect the study was designed to detect. Missing data handling is another recurring concern: authors should specify whether missing data were handled through complete-case analysis, multiple imputation, or another approach, and justify that choice. For clinical trials, the intention-to-treat principle should be addressed explicitly, even if per-protocol analyses are also reported. Blinding, randomization procedures, and allocation concealment should be described with enough specificity that a reader could evaluate whether the design adequately guards against bias.

For molecular biology work, reviewers in this journal have well-established expectations around experimental documentation. Antibody validation is a persistent concern: catalog numbers, clone identifiers, and validation evidence should accompany every antibody used, rather than relying on vendor claims alone. Western blot quantification requires loading controls to be shown, and band quantification should be reported with appropriate normalization. These are not bureaucratic formalities; they are the minimum documentation needed for another laboratory to evaluate or reproduce the findings.

Methodology standards are not uniform across all research traditions. Qualitative and interpretive work demands its own forms of rigor: transparency about sampling rationale, coding procedures, and the researcher's positionality are the qualitative equivalents of the quantitative concerns listed above. Whatever the methodology, the underlying principle is the same: readers and reviewers need enough information to assess the trustworthiness of the work.

04 Statistical Reporting and Replication

The expectations around statistical reporting have shifted considerably over the past decade, and PLoS ONE, as a journal committed to methodological soundness, reflects those evolving norms. Authors preparing quantitative manuscripts should be aware that p-values alone are no longer considered sufficient evidence of a meaningful finding. Reviewers increasingly expect effect sizes to be reported alongside inferential statistics, because effect sizes communicate the magnitude of a relationship or difference in ways that p-values cannot. Confidence intervals, which convey both the direction and precision of an estimate, are similarly valued. This shift away from null-hypothesis significance testing as the sole arbiter of publishability is well underway, and manuscripts that rely exclusively on p < 0.05 as their primary evidence may face pointed reviewer questions.

Pre-registration of hypotheses and analysis plans, through platforms such as the Open Science Framework or AsPredicted, has become an increasingly respected practice, particularly for confirmatory research. Pre-registration guards against HARKing (Hypothesizing After Results are Known), a practice that inflates false-positive rates and undermines the credibility of a literature. Even if a study was not pre-registered, authors can strengthen their manuscript by clearly distinguishing between analyses that were planned in advance and those that were exploratory. This distinction matters: exploratory findings are valuable, but they carry different epistemic weight than confirmatory tests and should be framed accordingly.

The broader context here is the replication crisis, which has reshaped expectations across the life sciences and beyond. Transparent methods, openly available materials, and honest reporting of null or unexpected results are now recognized as markers of scientific integrity rather than signs of a weak study. For qualitative and interpretive research, the equivalent of replication is auditability: a clear audit trail, a documented coding framework, and a reflexivity statement that acknowledges the researcher's perspective and how it may have shaped interpretation. These practices do not make qualitative work more "scientific" in a narrow sense; they make it more trustworthy on its own terms.

05 Pre-Submission Checklist

06 How PeerPanel Reviews Your Manuscript

Before your manuscript reaches PLoS ONE's editorial team, PeerPanel runs it past five specialist agents, each focused on a distinct dimension of manuscript quality.

07 Where to Find Author Guidelines

Authors preparing a submission to PLoS ONE should consult the journal's official instructions directly at plosone.org. The journal's own guidelines are the authoritative source for formatting requirements, word limits, reference style, figure specifications, and submission procedures. These details change periodically, and PeerPanel does not reproduce or summarize them. Reading the official author guidelines carefully before finalizing your manuscript is an essential step that no pre-submission tool can substitute for.